Us Bancorp \De\ Lexicon Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$1.3 - $3.58 $1,560 - $4,296	1,200 New	1,200 $2,000
Q4 2018 Feb 13, 2019	SELL	$6.15 - $10.51 $787 - $1,345	-128 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$7.8 - $13.69 $998 - $1,752	128 New	128 $2,000
Q4 2017 Feb 02, 2018	SELL	$8.77 - $12.28 $947 - $1,326	-108 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$12.17 - $16.3 $1,314 - $1,760	108	108 $1,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $143M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.